Evergreen Health Multiple Sclerosis Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis3 trials

Phase

• Phase 42 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

  NCT05090371· Phase 4· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

  NCT03650114· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

  NCT05084638· Phase 4· Novartis Pharmaceuticals· Source